JoVE Logo

Sign In

National Cancer Center Japan

1 ARTICLES PUBLISHED IN JoVE

image

Immunological Elimination of Undifferentiated Human Pluripotent Stem Cells Using Pluripotent State-Specific Antigen, Glypican-3
Marina Okada 1, Shugo Tohyama 1, Jun Fujita 1, Tetsuya Nakatsura 2, Keiichi Fukuda 1
1Department of Cardiology, Keio University School of Medicine, 2Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Japan

Regenerative therapies using human induced pluripotent stem cells (hiPSCs) have recently attracted much attention. In this study, we use anticancer immunotherapy with peptide vaccination to prevent hiPSC-derived tumorigenesis. Our results show that glypican-3 (GPC3) works as a pluripotent state-specific immunogenic antigen in hiPSCs.

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved